Basic Information
BiomX is a microbiome company developing customized phage therapies designed to target and eradicate harmful bacteria implicated in chronic diseases such as inflammatory bowel disease (IBD) and colorectal cancer (CRC), as well as bacteria affecting skin appearance. We have discovered and validated proprietary bacterial targets and tailored natural and engineered phage components to address these targets.